Handok
HANDOK Inc. operates as a pharmaceutical company. The company provides prescription and OTC drugs; medical devices, such as blood pressure monitors, cholesterol monitoring systems, insulin pumps, self-monitoring system of blood glucose, and blood glucose monitoring system; in vitro diagnostic medical devices; as well as life science products. It also offers healthcare products comprising food sup… Read more
Handok (002390) - Total Liabilities
Latest total liabilities as of September 2025: ₩536.54 Billion KRW
Based on the latest financial reports, Handok (002390) has total liabilities worth ₩536.54 Billion KRW as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Handok - Total Liabilities Trend (2011–2024)
This chart illustrates how Handok's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Handok Competitors by Total Liabilities
The table below lists competitors of Handok ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Kronos Bio Inc
NASDAQ:KRON
|
USA | $28.33 Million |
|
JASTECH Ltd
KQ:090470
|
Korea | ₩49.98 Billion |
|
CoTec Holdings Corp.
V:CTH
|
Canada | CA$4.35 Million |
|
Lavras Gold Corp.
OTCQX:LGCFF
|
USA | $1.55 Million |
|
Los Andes Copper Ltd
OTCQX:LSANF
|
USA | $24.03 Million |
|
Yangarra Resources Ltd
PINK:YGRAF
|
USA | $290.53 Million |
|
Taokaenoi Food & Marketing Public Company Limited
BK:TKN
|
Thailand | ฿1.92 Billion |
|
D0X
F:D0X
|
Germany | €164.00K |
Liability Composition Analysis (2011–2024)
This chart breaks down Handok's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.78 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.02 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.67 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Handok's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Handok (2011–2024)
The table below shows the annual total liabilities of Handok from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩499.49 Billion | +11.07% |
| 2023-12-31 | ₩449.71 Billion | -8.08% |
| 2022-12-31 | ₩489.25 Billion | +6.92% |
| 2021-12-31 | ₩457.57 Billion | +4.69% |
| 2020-12-31 | ₩437.08 Billion | +8.01% |
| 2019-12-31 | ₩404.67 Billion | +19.29% |
| 2018-12-31 | ₩339.24 Billion | -2.69% |
| 2017-12-31 | ₩348.63 Billion | +4.51% |
| 2016-12-31 | ₩333.60 Billion | +47.04% |
| 2015-12-31 | ₩226.88 Billion | +9.23% |
| 2014-12-31 | ₩207.71 Billion | +15.88% |
| 2013-12-31 | ₩179.25 Billion | +20.19% |
| 2012-12-31 | ₩149.14 Billion | +14.83% |
| 2011-12-31 | ₩129.88 Billion | -- |